Maternal-fetal transfer of anti-N-methyl-D-aspartate receptor antibodies.
Obstet Gynecol
; 125(5): 1056-1058, 2015 May.
Article
em En
| MEDLINE
| ID: mdl-25710615
ABSTRACT
BACKGROUND:
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a neuroautoimmune disease commonly associated with ovarian teratomas. It is characterized by neuropsychiatric symptoms, seizures, and autonomic instability. Few cases are described in pregnancy, and little is known about potential fetal effects. CASE Anti-NMDA receptor encephalitis was diagnosed at 24 weeks of gestation. No improvement occurred with intravenous immunoglobulin, methylprednisolone, and plasmapheresis. Imaging was unremarkable. Cesarean delivery with concurrent bilateral oophorectomy resulted in prompt maternal improvement. Antibody titers were positive in cord blood.CONCLUSION:
Anti-N-methyl-D-aspartate receptor encephalitis in pregnancy can lead to NMDA receptor antibodies in the fetal circulation. Pregnancy interruption through early delivery with or without oophorectomy may accelerate maternal recovery.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Complicações Neoplásicas na Gravidez
/
Feto
/
Encefalite Antirreceptor de N-Metil-D-Aspartato
/
Troca Materno-Fetal
/
Anticorpos
Limite:
Adult
/
Female
/
Humans
/
Male
/
Newborn
/
Pregnancy
Idioma:
En
Revista:
Obstet Gynecol
Ano de publicação:
2015
Tipo de documento:
Article